88
|
298
|
3r9nA |
Cdk2 in complex with inhibitor rc-2-21 |
77
|
298
|
3r8lA |
Cdk2 in complex with inhibitor l3-4 |
83
|
298
|
3r7yA |
Cdk2 in complex with inhibitor kvr-2-88 |
92
|
298
|
3ri1A |
Crystal structure of the catalytic domain of fgfr2 kinase in complex with arq 069 |
73
|
313
|
3rcdA |
Her2 kinase domain complexed with tak-285 |
87
|
298
|
3r8vA |
Cdk2 in complex with inhibitor rc-1-135 |
79
|
298
|
3rk7A |
Cdk2 in complex with inhibitor rc-2-71 |
110
|
349
|
3rinA |
P38 kinase crystal structure in complex with small molecule inhibitor |
80
|
268
|
3repA |
Crystal structure of the ilk/alpha-parvin core complex (mnatp) |
83
|
298
|
3raiA |
Cdk2 in complex with inhibitor kvr-1-160 |
76
|
298
|
3r8zA |
Cdk2 in complex with inhibitor rc-1-136 |
80
|
298
|
3r7vA |
Cdk2 in complex with inhibitor kvr-1-9 |
84
|
298
|
3rhkA |
Crystal structure of the catalytic domain of c-met kinase in complex with arq 197 |
78
|
298
|
3rakA |
Cdk2 in complex with inhibitor rc-2-32 |
80
|
298
|
3r9dA |
Cdk2 in complex with inhibitor rc-2-135 |
79
|
298
|
3r7eA |
Cdk2 in complex with inhibitor kvr-1-67 |
79
|
298
|
3rk9A |
Cdk2 in complex with inhibitor rc-2-74 |
84
|
301
|
3rhxA |
Crystal structure of the catalytic domain of fgfr1 kinase in complex with arq 069 |
88
|
297
|
3r9rA |
Structure of a phosphoribosylaminoimidazole-succinocarboxamide synthase from mycobacterium abscessus atcc 19977 / dsm 44196 |
81
|
298
|
3r8pA |
Cdk2 in complex with inhibitor nsk-mc1-6 |
83
|
271
|
3fpqA |
Crystal structure of the kinase domain of wnk1 |
99
|
293
|
3fxzA |
Crystal structure of pak1 kinase domain with ruthenium complex lambda-fl172 |
92
|
305
|
3r7oA |
Structure of dually phosphorylated c-met receptor kinase in complex with an mk-2461 analog |
79
|
273
|
3bwfA |
Crystal structure of the human pim1 in complex with an osmium compound |
106
|
327
|
2oxyA |
Protein kinase ck2 in complex with tetrabromobenzoimidazole derivatives k17, k22 and k32 |
83
|
298
|
2iw8A |
Structure of human thr160-phospho cdk2-cyclin a f82h-l83v-h84d mutant with an o6-cyclohexylmethylguanine inhibitor |
74
|
361
|
2lavA |
Nmr solution structure of human vaccinia-related kinase 1 |
86
|
298
|
2iw9A |
Structure of human thr160-phospho cdk2-cyclin a complexed with a bisanilinopyrimidine inhibitor |
75
|
272
|
5to8A |
Selectivity switch between fak and pyk2: macrocyclization of fak inhibitors improves pyk2 potency |
83
|
286
|
5tozA |
Jak3 with covalent inhibitor pf-06651600 |
92
|
282
|
5tt7A |
Discovery of tak-659, an orally available investigational inhibitor of spleen tyrosine kinase (syk) |
86
|
278
|
5tr6A |
Discovery of tak-659, an orally available investigational inhibitor of spleen tyrosine kinase (syk) |
82
|
286
|
5tkdA |
Crystal structure of tyrosine kinase 2 jh2 (pseudo kinase domain) complexed with 6-[(3,5-dimethylphe nyl)amino]-8- (methylamino)imidazo[1,2-b]pyridazine-3-carbo xamide |
76
|
274
|
5tf9A |
Crystal structure of wnk1 in complex with mn2+amppnp and wnk476 |
87
|
302
|
5t3qA |
Crystal structure of the c-met kinase domain in complex with a pyrazolone inhibitor |
81
|
275
|
5t68A |
Crystal structure of syk catalytic domain in complex with a furo[3,2-d]pyrimidine |
140
|
464
|
5t6kA |
Crystal structure of tgcdpk1 from toxoplasma gondii complexed with gw780159x |
108
|
363
|
5ceiA |
Crystal structure of cdk8:cyclin c complex with compound 22 |
93
|
281
|
5cenA |
Crystal structure of dlk (kinase domain) |
93
|
282
|
5ceqA |
Dlk in complex with inhibitor 2-((1-cyclopentyl-5-(1-(oxetan-3-yl)piperidin-4-yl)-1h-pyrazol-3-yl)amino)isonicotinonitrile |
120
|
348
|
5byzA |
Erk5 in complex with small molecule |
90
|
323
|
5c8mA |
Egfr kinase domain mutant "tmlr" with compound 17 |
83
|
286
|
5lvlA |
Human pdk1 kinase domain in complex with compound ps653 bound to the atp-binding site |
84
|
306
|
5l6wL |
Structure of the limk1-atpgammas-cfl1 complex |
80
|
273
|
5kziA |
Crystal structure of human pim-1 kinase in complex with an imidazopyridazine inhibitor. |
84
|
287
|
5ackA |
Human pdk1 kinase domain in complex with allosteric compound 7 bound to the pif-pocket |
95
|
291
|
4zjjA |
Pak1 in complex with (s)-n-(tert-butyl)-3-((2-chloro-5-ethyl-8-fluoro-dibenzodiazepin-11-yl)amino)pyrrolidine-1-carboxamide |
89
|
291
|
5c03A |
Crystal structure of kinase |
83
|
266
|
5l8jA |
Aurora-a kinase domain in complex with vnar-d01 s93r |
83
|
295
|
4zk5A |
Map4k4 in complex with inhibitor gne-495 |